Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Price:
1.15 USD
-1.71%
Market Closed
Updated:
May 15, 2024
Adaptimmune Therapeutics PLC
Total Other Income
|
Adaptimmune Therapeutics PLC
Total Other Income Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
Total Other Income
-$807k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Total Other Income
-$5.4m
|
CAGR 3-Years
-160%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Total Other Income
$261k
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Total Other Income
-£897k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Total Other Income
£1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Adaptimmune Therapeutics PLC's Total Other Income?
Total Other Income
-807k
USD
-807k
USD
Based on the financial report for Dec 31, 2023, Adaptimmune Therapeutics PLC's Total Other Income amounts to -807k USD.
What is Adaptimmune Therapeutics PLC's Total Other Income growth rate?
Total Other Income CAGR 5Y
43%
43%
Over the last year, the Total Other Income growth was -49%.
You don't have any saved screeners yet
